H.B. 434

1

PHARMACY PRACTICE ACT MODIFICATIONS
2 2012 GENERAL SESSION
3 STATE OF UTAH
4 Chief Sponsor: Evan J. Vickers
5 Senate Sponsor: Todd Weiler
6
7 LONG TITLE
8 General Description:
9 This bill amends the Pharmacy Practice Act.
10 Highlighted Provisions:
11 This bill:
12 . amends the definition of a pharmacy preceptor; and
13 . amends provisions related to a prescribing practitioner providing sample drugs to a
14 patient.
15 Money Appropriated in this Bill:
16 None
17 Other Special Clauses:
18 None
19 Utah Code Sections Affected:
20 AMENDS:
21 58-17b-102, as last amended by Laws of Utah 2010, Chapter 101
22 58-17b-610, as enacted by Laws of Utah 2004, Chapter 280
23
24 Be it enacted by the Legislature of the state of Utah:
25 Section 1. Section 58-17b-102 is amended to read:
26 58-17b-102. Definitions.
27 In addition to the definitions in Section 58-1-102 , as used in this chapter:

28 (1) "Administering" means:
29 (a) the direct application of a prescription drug or device, whether by injection,
30 inhalation, ingestion, or by any other means, to the body of a human patient or research subject
31 by another person; or
32 (b) the placement by a veterinarian with the owner or caretaker of an animal or group
33 of animals of a prescription drug for the purpose of injection, inhalation, ingestion, or any other
34 means directed to the body of the animal by the owner or caretaker in accordance with written
35 or verbal directions of the veterinarian.
36 (2) "Adulterated drug or device" means a drug or device considered adulterated under
37 21 U.S.C.S. Sec. 351 (2003).
38 (3) (a) "Analytical laboratory" means a facility in possession of prescription drugs for
39 the purpose of analysis.
40 (b) "Analytical laboratory" does not include a laboratory possessing prescription drugs
41 used as standards and controls in performing drug monitoring or drug screening analysis if the
42 prescription drugs are prediluted in a human or animal body fluid, human or animal body fluid
43 components, organic solvents, or inorganic buffers at a concentration not exceeding one
44 milligram per milliliter when labeled or otherwise designated as being for in vitro diagnostic
45 use.
46 (4) "Animal euthanasia agency" means an agency performing euthanasia on animals by
47 the use of prescription drugs.
48 (5) "Automated pharmacy systems" includes mechanical systems which perform
49 operations or activities, other than compounding or administration, relative to the storage,
50 packaging, dispensing, or distribution of medications, and which collect, control, and maintain
51 all transaction information.
52 (6) "Beyond use date" means the date determined by a pharmacist and placed on a
53 prescription label at the time of dispensing that indicates to the patient or caregiver a time
54 beyond which the contents of the prescription are not recommended to be used.
55 (7) "Branch pharmacy" means a pharmacy or other facility in a rural or medically
56 underserved area, used for the storage and dispensing of prescription drugs, which is dependent
57 upon, stocked by, and supervised by a pharmacist in another licensed pharmacy designated and
58 approved by the division as the parent pharmacy.

59 (8) "Board of pharmacy" or "board" means the Utah State Board of Pharmacy created
60 in Section 58-17b-201 .
61 (9) "Centralized prescription processing" means the processing by a pharmacy of a
62 request from another pharmacy to fill or refill a prescription drug order or to perform
63 processing functions such as dispensing, drug utilization review, claims adjudication, refill
64 authorizations, and therapeutic interventions.
65 (10) "Class A pharmacy" means a pharmacy located in Utah that is authorized as a
66 retail pharmacy to compound or dispense a drug or dispense a device to the public under a
67 prescription order.
68 (11) "Class B pharmacy":
69 (a) means a pharmacy located in Utah:
70 (i) that is authorized to provide pharmaceutical care for patients in an institutional
71 setting; and
72 (ii) whose primary purpose is to provide a physical environment for patients to obtain
73 health care services; and
74 (b) (i) includes closed-door, hospital, clinic, nuclear, and branch pharmacies; and
75 (ii) pharmaceutical administration and sterile product preparation facilities.
76 (12) "Class C pharmacy" means a pharmacy located in Utah that is authorized to
77 engage in the manufacture, production, wholesale, or distribution of drugs or devices.
78 (13) "Class D pharmacy" means a nonresident pharmacy.
79 (14) "Class E pharmacy" means all other pharmacies.
80 (15) "Closed-door pharmacy" means a pharmacy that provides pharmaceutical care to a
81 defined and exclusive group of patients who have access to the services of the pharmacy
82 because they are treated by or have an affiliation with a specific entity, including a health
83 maintenance organization or an infusion company, but not including a hospital pharmacy, a
84 retailer of goods to the general public, or the office of a practitioner.
85 (16) "Collaborative pharmacy practice" means a practice of pharmacy whereby one or
86 more pharmacists have jointly agreed, on a voluntary basis, to work in conjunction with one or
87 more practitioners under protocol whereby the pharmacist may perform certain pharmaceutical
88 care functions authorized by the practitioner or practitioners under certain specified conditions
89 or limitations.

90 (17) "Collaborative pharmacy practice agreement" means a written and signed
91 agreement between one or more pharmacists and one or more practitioners that provides for
92 collaborative pharmacy practice for the purpose of drug therapy management of patients and
93 prevention of disease of human subjects.
94 (18) (a) "Compounding" means the preparation, mixing, assembling, packaging, or
95 labeling of a limited quantity drug, sterile product, or device:
96 (i) as the result of a practitioner's prescription order or initiative based on the
97 practitioner, patient, or pharmacist relationship in the course of professional practice;
98 (ii) for the purpose of, or as an incident to, research, teaching, or chemical analysis and
99 not for sale or dispensing; or
100 (iii) in anticipation of prescription drug orders based on routine, regularly observed
101 prescribing patterns.
102 (b) "Compounding" does not include:
103 (i) the preparation of prescription drugs by a pharmacist or pharmacy intern for sale to
104 another pharmacist or pharmaceutical facility;
105 (ii) the preparation by a pharmacist or pharmacy intern of any prescription drug in a
106 dosage form which is regularly and commonly available from a manufacturer in quantities and
107 strengths prescribed by a practitioner; or
108 (iii) the preparation of a prescription drug, sterile product, or device which has been
109 withdrawn from the market for safety reasons.
110 (19) "Confidential information" has the same meaning as "protected health
111 information" under the Standards for Privacy of Individually Identifiable Health Information,
112 45 C.F.R. Parts 160 and 164.
113 (20) "Controlled substance" has the same definition as in Section 58-37-2 .
114 (21) "Dietary supplement" has the same meaning as Public Law Title 103, Chapter
115 417, Sec. 3a(ff) which is incorporated by reference.
116 (22) "Dispense" means the interpretation, evaluation, and implementation of a
117 prescription drug order or device or nonprescription drug or device under a lawful order of a
118 practitioner in a suitable container appropriately labeled for subsequent administration to or use
119 by a patient, research subject, or an animal.
120 (23) "Distribute" means to deliver a drug or device other than by administering or

121 dispensing.
122 (24) (a) "Drug" means:
123 (i) a substance recognized in the official United States Pharmacopoeia, Official
124 Homeopathic Pharmacopoeia of the United States, or Official National Formulary, or any
125 supplement to any of them, intended for use in the diagnosis, cure, mitigation, treatment, or
126 prevention of disease in humans or animals;
127 (ii) a substance that is required by any applicable federal or state law or rule to be
128 dispensed by prescription only or is restricted to administration by practitioners only;
129 (iii) a substance other than food intended to affect the structure or any function of the
130 body of humans or other animals; and
131 (iv) substances intended for use as a component of any substance specified in
132 Subsections (24)(a)(i), (ii), (iii), and (iv).
133 (b) "Drug" does not include dietary supplements.
134 (25) "Drug product equivalent" means a drug product that is designated as the
135 therapeutic equivalent of another drug product in the Approved Drug Products with
136 Therapeutic Equivalence Evaluations prepared by the Center for Drug Evaluation and Research
137 of the Federal Food and Drug Administration.
138 (26) "Drug regimen review" includes the following activities:
139 (a) evaluation of the prescription drug order and patient record for:
140 (i) known allergies;
141 (ii) rational therapy-contraindications;
142 (iii) reasonable dose and route of administration; and
143 (iv) reasonable directions for use;
144 (b) evaluation of the prescription drug order and patient record for duplication of
145 therapy;
146 (c) evaluation of the prescription drug order and patient record for the following
147 interactions:
148 (i) drug-drug;
149 (ii) drug-food;
150 (iii) drug-disease; and
151 (iv) adverse drug reactions; and

152 (d) evaluation of the prescription drug order and patient record for proper utilization,
153 including over- or under-utilization, and optimum therapeutic outcomes.
154 (27) "Drug sample" means a prescription drug packaged in small quantities consistent
155 with limited dosage therapy of the particular drug, which is marked "sample", is not intended to
156 be sold, and is intended to be provided to practitioners for the immediate needs of patients for
157 trial purposes or to provide the drug to the patient until a prescription can be filled by the
158 patient.
159 (28) "Electronic signature" means a trusted, verifiable, and secure electronic sound,
160 symbol, or process attached to or logically associated with a record and executed or adopted by
161 a person with the intent to sign the record.
162 (29) "Electronic transmission" means transmission of information in electronic form or
163 the transmission of the exact visual image of a document by way of electronic equipment.
164 (30) "Extern" means a college of pharmacy student enrolled in a college coordinated
165 practical experience program in a health care setting under the supervision of a preceptor, as
166 defined in this act, and approved by a college of pharmacy.
167 (31) "Hospital pharmacy" means a pharmacy providing pharmaceutical care to
168 inpatients of a general acute hospital or specialty hospital licensed by the Department of Health
169 under Title 26, Chapter 21, Health Care Facility Licensing and Inspection Act.
170 (32) "Legend drug" has the same meaning as prescription drug.
171 (33) "Licensed pharmacy technician" means an individual licensed with the division,
172 that may, under the supervision of a pharmacist, perform the activities involved in the
173 technician practice of pharmacy.
174 (34) "Manufacturer" means a person or business physically located in Utah licensed to
175 be engaged in the manufacturing of drugs or devices.
176 (35) (a) "Manufacturing" means:
177 (i) the production, preparation, propagation, conversion, or processing of a drug or
178 device, either directly or indirectly, by extraction from substances of natural origin or
179 independently by means of chemical or biological synthesis, or by a combination of extraction
180 and chemical synthesis, and includes any packaging or repackaging of the substance or labeling
181 or relabeling of its container; and
182 (ii) the promotion and marketing of such drugs or devices.

183 (b) "Manufacturing" includes the preparation and promotion of commercially available
184 products from bulk compounds for resale by pharmacies, practitioners, or other persons.
185 (c) "Manufacturing" does not include the preparation or compounding of a drug by a
186 pharmacist, pharmacy intern, or practitioner for that individual's own use or the preparation,
187 compounding, packaging, labeling of a drug, or incident to research, teaching, or chemical
188 analysis.
189 (36) "Medical order" means a lawful order of a practitioner which may include a
190 prescription drug order.
191 (37) "Medication profile" or "profile" means a record system maintained as to drugs or
192 devices prescribed for a pharmacy patient to enable a pharmacist or pharmacy intern to analyze
193 the profile to provide pharmaceutical care.
194 (38) "Misbranded drug or device" means a drug or device considered misbranded under
195 21 U.S.C.S. Sec. 352 (2003).
196 (39) (a) "Nonprescription drug" means a drug which:
197 (i) may be sold without a prescription; and
198 (ii) is labeled for use by the consumer in accordance with federal law.
199 (b) "Nonprescription drug" includes homeopathic remedies.
200 (40) "Nonresident pharmacy" means a pharmacy located outside of Utah that sells to a
201 person in Utah.
202 (41) "Nuclear pharmacy" means a pharmacy providing radio-pharmaceutical service.
203 (42) "Out-of-state mail service pharmacy" means a pharmaceutical facility located
204 outside the state that is licensed and in good standing in another state, that:
205 (a) ships, mails, or delivers by any lawful means a dispensed legend drug to a patient in
206 this state pursuant to a lawfully issued prescription;
207 (b) provides information to a patient in this state on drugs or devices which may
208 include, but is not limited to, advice relating to therapeutic values, potential hazards, and uses;
209 or
210 (c) counsels pharmacy patients residing in this state concerning adverse and therapeutic
211 effects of drugs.
212 (43) "Patient counseling" means the written and oral communication by the pharmacist
213 or pharmacy intern of information, to the patient or caregiver, in order to ensure proper use of

214 drugs, devices, and dietary supplements.
215 (44) "Pharmaceutical administration facility" means a facility, agency, or institution in
216 which:
217 (a) prescription drugs or devices are held, stored, or are otherwise under the control of
218 the facility or agency for administration to patients of that facility or agency;
219 (b) prescription drugs are dispensed to the facility or agency by a licensed pharmacist
220 or pharmacy intern with whom the facility has established a prescription drug supervising
221 relationship under which the pharmacist or pharmacy intern provides counseling to the facility
222 or agency staff as required, and oversees drug control, accounting, and destruction; and
223 (c) prescription drugs are professionally administered in accordance with the order of a
224 practitioner by an employee or agent of the facility or agency.
225 (45) (a) "Pharmaceutical care" means carrying out the following in collaboration with a
226 prescribing practitioner, and in accordance with division rule:
227 (i) designing, implementing, and monitoring a therapeutic drug plan intended to
228 achieve favorable outcomes related to a specific patient for the purpose of curing or preventing
229 the patient's disease;
230 (ii) eliminating or reducing a patient's symptoms; or
231 (iii) arresting or slowing a disease process.
232 (b) "Pharmaceutical care" does not include prescribing of drugs without consent of a
233 prescribing practitioner.
234 (46) "Pharmaceutical facility" means a business engaged in the dispensing, delivering,
235 distributing, manufacturing, or wholesaling of prescription drugs or devices within or into this
236 state.
237 (47) (a) "Pharmaceutical wholesaler or distributor" means a pharmaceutical facility
238 engaged in the business of wholesale vending or selling of any prescription drug or device to
239 other than the consumer or user of the prescription drug or device, which the pharmaceutical
240 facility has not produced, manufactured, compounded, or dispensed.
241 (b) "Pharmaceutical wholesaler or distributor" does not include a pharmaceutical
242 facility carrying out the following business activities:
243 (i) intracompany sales;
244 (ii) the sale, purchase, or trade of a prescription drug or device, or offer to sell,

245 purchase or trade a prescription drug or device between hospitals or other health care facilities
246 that are under common ownership or control of the management and operation of the facilities;
247 (iii) the sale, purchase, or trade of a prescription drug or device, or offer to sell,
248 purchase, or trade a prescription drug or device for emergency medical reasons, or to supply
249 another pharmaceutical facility to alleviate a temporary shortage; or
250 (iv) the distribution of a prescription drug or device as a sample by representatives of a
251 manufacturer.
252 (48) "Pharmacist" means an individual licensed by this state to engage in the practice
253 of pharmacy.
254 (49) "Pharmacist-in-charge" means a pharmacist currently licensed in good standing
255 who accepts responsibility for the operation of a pharmacy in conformance with all laws and
256 rules pertinent to the practice of pharmacy and the distribution of drugs, and who is personally
257 in full and actual charge of the pharmacy and all personnel.
258 (50) "Pharmacist preceptor" means a licensed pharmacist in good standing with [two]
259 one or more years of licensed experience. The preceptor serves as a teacher, example of
260 professional conduct, and supervisor of interns in the professional practice of pharmacy.
261 (51) "Pharmacy" means any place where:
262 (a) drugs are dispensed;
263 (b) pharmaceutical care is provided;
264 (c) drugs are processed or handled for eventual use by a patient; or
265 (d) drugs are used for the purpose of analysis or research.
266 (52) "Pharmacy benefits manager or coordinator" means a person or entity that
267 administers the prescription drug or device portion of a health insurance plan on behalf of a
268 self-insured employer, insurance company, health maintenance organization, or other plan
269 sponsor, as defined by rule.
270 (53) "Pharmacy intern" means an individual licensed by this state to engage in practice
271 as a pharmacy intern.
272 (54) "Pharmacy technician training program" means an approved technician training
273 program providing education for pharmacy technicians.
274 (55) (a) "Practice as a licensed pharmacy technician" means engaging in practice as a
275 pharmacy technician under the general supervision of a licensed pharmacist and in accordance

276 with a scope of practice defined by division rule made in collaboration with the board.
277 (b) "Practice as a licensed pharmacy technician" does not include:
278 (i) performing a drug utilization review, prescription drug order clarification from a
279 prescriber, final review of the prescription and prescribed drug prepared for dispensing,
280 dispensing of the drug, or counseling a patient with respect to a prescription drug;
281 (ii) counseling regarding nonprescription drugs and dietary supplements unless
282 delegated by the supervising pharmacist; or
283 (iii) receiving new prescription drug orders when communicating telephonically or
284 electronically unless the original information is recorded so the pharmacist may review the
285 prescription drug order as transmitted.
286 (56) "Practice of pharmacy" includes the following:
287 (a) providing pharmaceutical care;
288 (b) collaborative pharmacy practice in accordance with a collaborative pharmacy
289 practice agreement;
290 (c) compounding, packaging, labeling, dispensing, administering, and the coincident
291 distribution of prescription drugs or devices, provided that the administration of a prescription
292 drug or device is:
293 (i) pursuant to a lawful order of a practitioner when one is required by law; and
294 (ii) in accordance with written guidelines or protocols:
295 (A) established by the licensed facility in which the prescription drug or device is to be
296 administered on an inpatient basis; or
297 (B) approved by the division, in collaboration with the board and the Physicians
298 Licensing Board, created in Section 58-67-201 , if the prescription drug or device is to be
299 administered on an outpatient basis solely by a licensed pharmacist;
300 (d) participating in drug utilization review;
301 (e) ensuring proper and safe storage of drugs and devices;
302 (f) maintaining records of drugs and devices in accordance with state and federal law
303 and the standards and ethics of the profession;
304 (g) providing information on drugs or devices, which may include advice relating to
305 therapeutic values, potential hazards, and uses;
306 (h) providing drug product equivalents;

307 (i) supervising pharmacist's supportive personnel, pharmacy interns, and pharmacy
308 technicians;
309 (j) providing patient counseling, including adverse and therapeutic effects of drugs;
310 (k) providing emergency refills as defined by rule;
311 (l) telepharmacy; and
312 (m) formulary management intervention.
313 (57) "Practice of telepharmacy" means the practice of pharmacy through the use of
314 telecommunications and information technologies.
315 (58) "Practice of telepharmacy across state lines" means the practice of pharmacy
316 through the use of telecommunications and information technologies that occurs when the
317 patient is physically located within one jurisdiction and the pharmacist is located in another
318 jurisdiction.
319 (59) "Practitioner" means an individual currently licensed, registered, or otherwise
320 authorized by the appropriate jurisdiction to prescribe and administer drugs in the course of
321 professional practice.
322 (60) "Prescribe" means to issue a prescription:
323 (a) orally or in writing; or
324 (b) by telephone, facsimile transmission, computer, or other electronic means of
325 communication as defined by division rule.
326 (61) "Prescription" means an order issued:
327 (a) by a licensed practitioner in the course of that practitioner's professional practice or
328 by collaborative pharmacy practice agreement; and
329 (b) for a controlled substance or other prescription drug or device for use by a patient
330 or an animal.
331 (62) "Prescription device" means an instrument, apparatus, implement, machine,
332 contrivance, implant, in vitro reagent, or other similar or related article, and any component
333 part or accessory, which is required under federal or state law to be prescribed by a practitioner
334 and dispensed by or through a person or entity licensed under this chapter or exempt from
335 licensure under this chapter.
336 (63) "Prescription drug" means a drug that is required by federal or state law or rule to
337 be dispensed only by prescription or is restricted to administration only by practitioners.

338 (64) "Retail pharmacy" means a pharmaceutical facility dispensing prescription drugs
339 and devices to the general public.
340 (65) "Self-audit" means an internal evaluation of a pharmacy to determine compliance
341 with this chapter.
342 (66) "Supervising pharmacist" means a pharmacist who is overseeing the operation of
343 the pharmacy during a given day or shift.
344 (67) "Supportive personnel" means unlicensed individuals who:
345 (a) may assist a pharmacist, pharmacist preceptor, pharmacy intern, or licensed
346 pharmacy technician in nonjudgmental duties not included in the definition of the practice of
347 pharmacy, practice of a pharmacy intern, or practice of a licensed pharmacy technician, and as
348 those duties may be further defined by division rule adopted in collaboration with the board;
349 and
350 (b) are supervised by a pharmacist in accordance with rules adopted by the division in
351 collaboration with the board.
352 (68) "Unlawful conduct" is as defined in Sections 58-1-501 and 58-17b-501 .
353 (69) "Unprofessional conduct" is as defined in Sections 58-1-501 and 58-17b-502 and
354 may be further defined by rule.
355 (70) "Veterinary pharmaceutical facility" means a pharmaceutical facility that
356 dispenses drugs intended for use by animals or for sale to veterinarians for the administration
357 for animals.
358 Section 2. Section 58-17b-610 is amended to read:
359 58-17b-610. Patients' immediate needs.
360 (1) This chapter may not be construed to prevent the personal administration of drugs
361 or medicines by practitioners licensed to prescribe in order to supply the immediate needs of
362 [their] the practitioner's patients.
363 (2) Immediate need for a patient includes giving out drug samples [for up to a
364 three-day supply or the amount necessary to determine the best pharmaceutical agent for that
365 specific patient.] that:
366 (a) are not Schedule II drugs, opiods, or Benzodiazepines;
367 (b) are prepackaged by the original manufacturer;
368 (c) are provided to the prescribing practitioner free of charge and provided to the

369 patient free of any direct or indirect charge;
370 (d) do not exceed a 30-day supply for:
371 (i) controlled substances; or
372 (ii) non-controlled substances, unless a prescribing practitioner documents that
373 providing more than a 30-day supply is medically necessary; and
374 (e) (i) are marked on the immediate container to indicate that the drug is a sample; or
375 (ii) are recorded in the patient's chart with the name and number of samples provided.
376 (3) A prescribing practitioner who provides samples for a patient shall:
377 (a) comply with Subsection (2); and
378 (b) follow state and federal labeling requirements.




Legislative Review Note
as of 2-13-12 1:45 PM

Office of Legislative Research and General Counsel